Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling.
Redondo A, Paradela-Dobarro B, Moscoso I, Moure-Álvarez M, Cebro-Márquez M, González-Juanatey JR, García-Seara J, Álvarez E. Redondo A, et al. Among authors: paradela dobarro b. J Mol Med (Berl). 2021 Jul;99(7):943-953. doi: 10.1007/s00109-021-02054-6. Epub 2021 Feb 27. J Mol Med (Berl). 2021. PMID: 33641068
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Paradela-Dobarro B, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, Alvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Cardiovasc Diabetol. 2012 Aug 21;11:102. doi: 10.1186/1475-2840-11-102. Cardiovasc Diabetol. 2012. PMID: 22909322 Free PMC article.
Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: evidence in patients with acute myocardial infarction.
Paradela-Dobarro B, Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, González-Juanatey JR, Alvarez E. Paradela-Dobarro B, et al. Eur J Pharm Sci. 2013 Jul 16;49(4):512-8. doi: 10.1016/j.ejps.2013.05.001. Epub 2013 May 9. Eur J Pharm Sci. 2013. PMID: 23665412
Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Paradela-Dobarro B, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, González-Juanatey JR, Álvarez E. Raposeiras-Roubín S, et al. PLoS One. 2013 Sep 13;8(9):e74302. doi: 10.1371/journal.pone.0074302. eCollection 2013. PLoS One. 2013. PMID: 24058542 Free PMC article.
Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition.
Paradela-Dobarro B, Fernández-Trasancos Á, Bou-Teen D, Eiras S, González-Ferreiro R, Agra RM, Varela-Román A, Castro-Pais AI, Carreira MC, Casanueva FF, Álvarez E, González-Juanatey JR. Paradela-Dobarro B, et al. Cardiovasc Diabetol. 2017 Sep 15;16(1):115. doi: 10.1186/s12933-017-0598-3. Cardiovasc Diabetol. 2017. PMID: 28915840 Free PMC article.
Inflammatory effects of in vivo glycated albumin from cardiovascular patients.
Paradela-Dobarro B, Bravo SB, Rozados-Luís A, González-Peteiro M, Varela-Román A, González-Juanatey JR, García-Seara J, Alvarez E. Paradela-Dobarro B, et al. Biomed Pharmacother. 2019 May;113:108763. doi: 10.1016/j.biopha.2019.108763. Epub 2019 Mar 13. Biomed Pharmacother. 2019. PMID: 30875658 Free article.
24 results